OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers
Healthcare Law Blog
MARCH 17, 2022
On Thursday, March 16, the Office of the Inspector General for the Department of Health and Human Services (“OIG”) issued OIG Advisory Opinion (“AO”) No. 22-05 , relating to subsidization of certain Medicare cost-sharing obligations in the context of a clinical trial involving medical devices (the “Proposed Arrangement”).